Abbott Laboratories beats by $0.01, beats on revenue
Abbott Laboratories (NYSE:ABT): Q1 Non-GAAP EPS of $0.63 beats by $0.01; GAAP EPS of $0.38.
Revenue of $7.54B (+2.0% Y/Y) beats by $50M.
Nach dem Dip in den vergangenen Tagen (Danke Bernie Sanders!
) gehts heute mal wieder aufwärts...
Abbott Laboratories (NYSE:ABT): Q1 Non-GAAP EPS of $0.63 beats by $0.01; GAAP EPS of $0.38.
Revenue of $7.54B (+2.0% Y/Y) beats by $50M.
Nach dem Dip in den vergangenen Tagen (Danke Bernie Sanders!
